Healthcare provider profile · identity verified

Michael Goshorn

Family Practice · WEST ALLIS, WI · NPI 1750737367

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	373	110
Lisinopril	Lisinopril	303	83
Tamsulosin Hcl	Tamsulosin Hcl	278	71
Losartan Potassium	Losartan Potassium	264	73
Amlodipine Besylate	Amlodipine Besylate	260	65
Rosuvastatin Calcium	Rosuvastatin Calcium	246	78
Pantoprazole Sodium	Pantoprazole Sodium	227	63
Gabapentin	Gabapentin	197	47
Hydrochlorothiazide	Hydrochlorothiazide	172	52
Metformin Hcl Er	Metformin Hcl	167	49
Metoprolol Succinate	Metoprolol Succinate	166	54
Albuterol Sulfate Hfa	Albuterol Sulfate	165	56
Omeprazole	Omeprazole	159	45
Levothyroxine Sodium	Levothyroxine Sodium	154	43
Furosemide	Furosemide	145	46
Simvastatin	Simvastatin	127	31
Metformin Hcl	Metformin Hcl	115	31
Bupropion Xl	Bupropion Hcl	102	28
Metoprolol Tartrate	Metoprolol Tartrate	92	27
Potassium Chloride	Potassium Chloride	92	21
Sertraline Hcl	Sertraline Hcl	91	23
Eliquis	Apixaban	86	19
Jardiance	Empagliflozin	85	22
Pravastatin Sodium	Pravastatin Sodium	85	20
Fluticasone Propionate	Fluticasone Propionate	78	33
Carvedilol	Carvedilol	77	23
Duloxetine Hcl	Duloxetine Hcl	76	28
Pregabalin	Pregabalin	76	20
Escitalopram Oxalate	Escitalopram Oxalate	74	21
Finasteride	Finasteride	74	17
Hydralazine Hcl	Hydralazine Hcl	68	21
Allopurinol	Allopurinol	67	18
Ozempic	Semaglutide	64	15
Tizanidine Hcl	Tizanidine Hcl	60	29
Trazodone Hcl	Trazodone Hcl	59	16
Trulicity	Dulaglutide	59	13
Valsartan	Valsartan	57	12
Montelukast Sodium	Montelukast Sodium	56	14
Clopidogrel	Clopidogrel Bisulfate	52	19
Meloxicam	Meloxicam	52	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	17
Xarelto	Rivaroxaban	50	11
Ezetimibe	Ezetimibe	47	13
Pioglitazone Hcl	Pioglitazone Hcl	46	15
Tramadol Hcl	Tramadol Hcl	46	13
Triamcinolone Acetonide	Triamcinolone Acetonide	41	28
Famotidine	Famotidine	40	suppressed
Buspirone Hcl	Buspirone Hcl	39	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	11
Prednisone	Prednisone	39	33
Diclofenac Sodium	Diclofenac Sodium	37	16
Fenofibrate	Fenofibrate	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	11
Symbicort	Budesonide/Formoterol Fumarate	34	12
Hydroxyzine Hcl	Hydroxyzine Hcl	33	16
Januvia	Sitagliptin Phosphate	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Atenolol	Atenolol	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	11
Nifedipine Er	Nifedipine	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Methylprednisolone	Methylprednisolone	25	14
Spironolactone	Spironolactone	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Linzess	Linaclotide	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Indapamide	Indapamide	19	suppressed
Ketoconazole	Ketoconazole	19	14
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Clonidine Hcl	Clonidine Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Diazepam	Diazepam	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Folic Acid	Folic Acid	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Atrovent Hfa	Ipratropium Bromide	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Baclofen	Baclofen	13	suppressed
Cephalexin	Cephalexin	13	12
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Metoprolol-Hydrochlorothiazide	Metoprolol/Hydrochlorothiazide	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error